Micristin 1 (Vincristine Sulphate Injection USp 1mg)

About Micristin 1 (Vincristine Sulphate Injection USp 1mg)

Vincristine  1 Injection is an anti-cancer medication used in the treatment of breast cancer, non-small cell lung cancer, pancreatic cancer, kidney cancer, blood cancer, multiple myeloma, lymphomas and bone cancer.

Vincristine  1 Injection is given as an injection into the vein under the supervision of a doctor. Your doctor will decide what dose is necessary and how often you need to take it. This will depend on what you are being treated for and may change from time to time. You should take it exactly as your doctor has advised. Taking it in the wrong way or taking too much can cause very serious side effects. It may take several weeks or months for you to see or feel the benefits but do not stop taking it unless your doctor tells you to.

The most common side effects of this medicine include hair loss, peripheral neuropathy (tingling and numbness of feet and hand), and constipation. This medicine may reduce the number of blood cells (white blood cells) in your blood, thereby, increasing the susceptibility to infections and fever. In some cases, it may also cause kidney disease related to uric acid level. Regular blood tests are required to check your blood cells along with heart, liver, and blood uric acid levels.

Many other medicines can affect, or be affected by, this medicine so let your doctor know all medications you are using. This medicine is not recommended during pregnancy or while breastfeeding. The use of effective contraception by both males and females during treatment is important to avoid pregnancy.  you are suggested to avoid direct contact of medicine with eyes, as it may cause eye irritation.

Targeted Cancer Therapy

Micristin 1 is a trusted antineoplastic agent recommended for the management of cancers like leukemia and lymphoma. Utilizing Vincristine Sulphate, it disrupts the cancer cell cycle, helping to prevent the proliferation of malignant cells. Its application is vital in multi-agent therapy protocols, maximizing therapeutic outcomes for patients.


Strict Administration Protocols

As a potent chemotherapy agent, Micristin 1 is strictly for intravenous administration under direct supervision of qualified healthcare professionals. It must never be administered intrathecally. All dosages are tailored by a licensed medical provider based on precise patient needs, ensuring both safety and efficacy in clinical management.


Storage and Handling Guidelines

Micristin 1 should always be stored between 2C to 8C and shielded from light exposure. Follow precise storage directives to preserve its efficacy over its 24-month shelf life. Proper handling and administration in a medical facility are crucial to ensure patient safety and product integrity during cancer treatment.